News this week that Facebook’s business practices continuously favored profits over societal interests adds to the series of events that showcased the company’s incredible lack of ethics these past few years. Documents leaked from a former product manager on Facebook’s civic misinformation team said the company’s practices were “putting lives at risk” to protect its business model. Conversely, in a WSJ series of articles last month, it was reported that some researchers found that as much as 6% of American users of Instagram (a Facebook company) traced the urge to kill themselves to Instagram. This did not discourage the firm from wanting to launch “Instagram for kids”, a project that was delayed because of yet another reputational crisis. It seems that increasingly, Facebook is employing tactics used by cigarette makers like Philip Morris in the 1970s and oil companies like Exxon in the 1980s to cover up the impact of its operations on society.
We have been quite bearish on Facebook and recommended shorting the stock (see our note “Life in the Shadow of Big Tech”, August 6, 2020) this past year – with no success in the past few months as the pandemic bolstered the firm’s profits and stock value. That said, criticism over the company’s practices have only grown since then – including in the lead up to the U.S. elections (and other political events in other countries).
The company’s stock price has shed about 15 percentage points due to mounting concerns of its handling of public health issues such as screen addiction and its policies around data privacy (or the lack thereof) following the publication of the above-mentioned WSJ article. In this context, we could see a global “Divest Facebook” emerge amongst investors worldwide. In fact, some groups are already pressuring asset owners to divest the stock following this week’s hearings in the U.S. Senate. In short, if regulatory risks of seeing Facebook being dismantled by Congress are not convincing enough already, investors should stay away from Facebook – even if only on reputational grounds.
To this end, Facebook’s CSRHub score, an aggregator of ESG scoring methodologies, also points towards growing reputational issues. To this point, the company’s aggregate ESG score fell substantially in recent months and we don’t expect it to improve anytime soon.
Moreover, according to Axios Harris, a polling firm which polls 40,000+ Americans and provides reputational rankings on the 100 most visible companies, Facebook ranked 98 on 100 in terms of reputation, just above Fox Corporation and the Trump Organization. In other words, according to the poll, of the top 100 most visible companies, Facebook has the third worst reputation – not something that will help its ESG scores. Perhaps more importantly, it’s hard to believe how Facebook will manage to attract talent and a larger slice of global marketing budgets going forward if it doesn’t start improving its image soon.
Furthermore, financial market participants are also realizing the embedded risks in holding Facebook’s stock. Smart money managers such as Hedge Funds have increased their short positions against the company in recent months; as a result, the short interest ratio is at its highest level since 2016.
That said, the stock remains a staple holding of many ETFs and retirement funds given the sheer size of its market capitalization. While long term investors hold about ¾ of the company’s float, we think that the former will start feeling the heat from their clients and stakeholders on the rationale of holding such a socially-toxic company as one of their main holdings.
Headlines last week mentioning British American Tobacco’s (BAT) role in negotiating bribes for Zimbabwe’s Mugabe regime raises yet another issue against the global tobacco industry. One could conclude that companies that sell deathly products don’t have too much of an issue with ethics after all.
Interestingly, it seems that despite the nature of the cigarette business, companies in the tobacco sector have become skilled at filling ESG questionnaires – yielding some the title of “the most ESG company” of all (Philip Morris). This is yet another blow against ESG ratings, one where companies have learned how to fill ESG questionnaires effectively even if their main product kills people and overburdens hospitals. To this end, it is not surprising to see that ESG scores of some of the world’s largest cigarette makers have increased to top quintiles (percentile scores) these past few years according to CSRHub, an ESG score aggregator.
Bloomberg also shows that about 50 “ESG” funds (out of 4,000 ESG funds) have holdings in the top five tobacco companies – not something one would expect when investing for a better world; we don’t see anything sustainable in cigarette-making.
While tobacco producers have long been an absolute no-brainer on investment grounds as savvy investors are typically attracted to disliked stocks with high dividend yields, the sector started to underperform in 2020 alongside the COVID pandemic. It appears that respiratory diseases don’t square well with having an extra smoke.
Looking at five-year price performance of tobacco stocks on a total return basis (i.e. including dividends), one sees that excluding the sector could even have proven beneficial to investors over the past few years. For those even savvier investors, shorting tobacco stocks could have yielded some significant alpha – not something that could have happened 20 years ago when smoking was “in”. Note that, as the chart below shows, Philip Morris is an exception: this company has outperformed its peers, most likely because it has been the most aggressive at attempting to diversify its revenues away from cigarettes (the company has set a goal to have less than half of its revenue derived by combustible products by 2025).
We expect this trend to get only bigger as smoking remains in constant decline in advanced economies such as the U.S., where the number of smokers halved to 16 percent of the population since the mid 1980s, according to Gallup polls.

Source: Tobacco and Smoking | Gallup Historical Trends
This is why many tobacco producers have pivoted into the cannabis business – some even suggesting that cannabis is a healthier alternative to tobacco. That said, the emerging narrative of cannabis as a “healthy” alternative to tobacco is currently being promoted by cigarette makers as a diversification strategy against a deadly product. We expect the recreational cannabis industry to plateau, especially since only a small number of Americans – about 12% – smoke marijuana.

Source: What Percentage of Americans Smoke Marijuana? (gallup.com)
Both for tobacco and cannabis, one could hardly argue that the market for smoking will grow in the coming years –this is what financial markets have been pricing lately – especially cannabis products, where the POTX index (world main cannabis producers) is down some 40 percentage points since 2019. To his end, both cannabis and tobacco underperformed the S&P 500 since 2019 and we don’t see a catalyst that will change the outlook.
Despite the deflating cannabis hype, the market capitalization of the top five cannabis producers (by market cap) is now twice that of cigarette makers – even though many cannabis producers have yet to declare a profit, let alone a dividend.
Cannabis producers – especially those focusing on medicinal products – have fared well during the COVID pandemic: perhaps work from home (WFH) enabled workers with more leisure time (with cameras off, obviously) and/or increased depression and anxiety. That said, cannabis stock prices started to fall earlier this year and we expect the trend to continue as the world returns to normalcy and adopts healthier habits. Finally, regulations with regard to cannabis usage will most likely get tighter as we better understand the larger effects of cannabis on public health outcomes.
After decades of rising inequality within nations as well as an inability to close the gap between rich and poor countries, there is mounting pressure and societal desire for a fairer playing field. This will manifest itself particularly in education and health care innovations and delivery. Moreover, the strengthening position of labor will mean that there is a tendency for middle class wages to rise on both a relative and absolute basis.
We expect the Social Inequalities theme to become more critical for investors over the next five years. We anticipate CEO pay to come under greater scrutiny, wealth redistribution to trend downwards through taxation instead of upwards (2017 tax cuts). We also believe that improved worker pay will result from a better bargaining position of workers amid a societal shift away from measuring the value of an individual by the size of his wallet towards a more balanced measure of worth. Moreover, with S&P 500 profit margins at a 5-year high, companies can really afford to remunerate workers more generously.
As investors become better attuned to these shifts, they will alter corporate behavior and subthemes addressing social inequalities will be attractive. Investable subthemes we expect to emerge stronger are educational technology (especially for post-secondary education) and health technology. The latter is likely to aid in democratizing patient services and reducing costs as well as providing solutions to improve life expectancy and quality of life.
We have written extensively on the social evolution of the investment landscape. The table below highlights the research notes since 2020 that address social inequalities with the companies identified by the research.
In the rest of the note, we examine the extent to which social inequalities have deteriorated. This supports our view that mitigating actions are likely.
President Biden’s vision is to build a high-care, low-carbon economy. A survey from Pew Research conducted before the pandemic had a plurality of responders indicating income inequalities as detrimental as well as four of their five top priorities agreeing with that diagnostic back then. Following the pandemic and a summer of climate disasters, we would expect even more support for a high-care, low-carbon economy.
A second report from Pew Research illustrates the extent to which income inequalities have increased over the last 50 years, and especially since 2000: nominal wages for lower income households have stagnated.
Moreover, the percentage of households that qualify as middle income has shrunk significantly compared to higher and lower income. Essentially, the rich are getting higher income, the number of middle income families is shrinking and lower income households are not seeing improvements.
It is perhaps not surprising that households with a higher income are accumulating far more wealth, while the rest of the population is getting poorer. In other words, both income inequality and wealth inequality are major challenges.
Moreover, another major inequality challenge is the state of U.S. health care. Health care costs in the United States as a percentage of the economy – at nearly 20% - have reached a disproportionate level.
Some of the increase in health care costs makes sense, since aging populations tend to put higher strains on health care services. However, with such high expenditures relative to the size of the economy, we should have seen vast improvements in life expectancy. The two graphs below illustrate that life expectancy in the United States has improved but not as much as in other countries over the last 50 years even though health care spending per individual is twice as high compared to many other developed countries that have seen greater life expectancy improvements.
Among the 5 countries analyzed, the United States is where the private sector is most present and where access is least universal.
Similarly to the fact that having a good health leads to better life outcomes, research also shows that a good education leads to higher income, greater access to health care, and a longer lifespan.
In their recent book “Deaths of Despair”, Anne Case and Angus Deaton chronicle the impact of education on the quality of life beginning with a diminished self worth that leads to greater drug and alcohol abuse as well as a higher suicide rate. They show that there is a strong positive correlation between educational attainments and life expectancy. Suffice to say that the link between education, income, health, and quality of life are inextricable. The current administration in the United States understands the issues and wants to enact change to address some of the underlying issues.
‘Lack of workers’ has become a rallying cry for U.S. businesses, large and small alike. To be sure, short-term factors related to the pandemic (fear of getting sick, government programs that skew incentives, reduced migrant workers) have created friction in the labor market, as people’s short-term priorities have been upended. But employee shortages began well before the COVID-19 pandemic and is rooted in multiple structural factors, including demographics, technology and social attitudes. These are long term, complex issues that will not change quickly.
Nonetheless, businesses have a very simple, effective tool that is guaranteed to alleviate the problem: wage hikes. And the miraculous thing about improving worker pay is that not only does it allow businesses to operate and generate revenues, but it also mitigates a major long-term investment theme that we believe will help determine alpha across equity portfolios: income inequality.
In our April 8th Note (Working Class Hero), we explain why and how income inequality is a priority for the current U.S. administration. We argued that since the government will prioritize reducing income inequality through both fiscal levers (taxation and spending packages) as well as the regulatory backdrop (e.g. minimum wage hikes and unionization laws), labor has an increased potential to affect corporate profitability and therefore equity returns in the coming years.
Labor and fiscal reform are not the only way to impact income inequality. Given the current tightness in the labor market, the laws of supply and demand suggest that the price of the good in question will rise. Indeed, there are already tentative signs of wage inflation. The significant (and hopeful!) twist for investors is that in the current environment, companies that lead with pay raises (i.e. opt to pay better wages first) stand to be rewarded for mitigating labor quality risks, rather than punished for a possible short-term drop in profitability.
The Current Landscape
It is well known that the Gini coefficient – a measure of income distribution – has risen in the U.S. (and elsewhere) over the past three decades. It is perhaps no wonder since median real wages have hardly budged over the same time frame.
It is also increasingly publicized that more and more businesses can not find qualified workers, at least not at current wages. For example, according to the U.S. Bureau of Labor Statistics, the job vacancy rate is at the highest level since records have been kept. Note that the number of jobs that remain unfilled are higher than average across all industries, but the most acute shortages are occurring in industries that notoriously offer lower wages and/or weaker contracts.
Why It Needs To Change
There are several reasons why income inequality should be viewed as unwelcome from an investors’ perspective, and we highlight two that are cited in recent work by the UN Principles for Responsible Investment (UNPRI):
- Inequality may change the risks and opportunities that affect the available universe of investment opportunities.
- Inequality might negatively affect the financial system in which investors participate, and the world in which beneficiaries live.
The implication is that there is a growing concern that income inequality will have negative consequences for investment returns. Meanwhile, the implications of a low wage backdrop are complex from an investor standpoint.
To be sure, the past several decades of strong corporate profitability owes itself to not only productivity growth but also an ability for corporate America to contain wage growth. Over the past 40 years, the share of income that has gone to labor has shrunk consistently, in favor of shareholders. In other words, corporations that were able to contain labor costs by keeping wages low were applauded by investors since it meant more profits delivered to shareholders.
However, there are increasing signs that a tipping point has been reached: low wages may be turning from a tailwind to a headwind from profitability. Clearly, when wages are too low, businesses are unable to attract qualified labor, with impacts falling ultimately on company value:
- High employee turnover: In environments where the supply of labor is tight (i.e. there is a shortage of workers), qualified individuals will be consistently lured toward companies that offer the most lucrative positions. This manifests itself in lower productivity and thus profitability.
- Product or service downgrades: low wage offers that attract only ill-qualified and/or poorly motivated employees means that the quality of output, whether it be customer service or a finished product, is at risk. This manifests itself in loss of revenue and thus profitability.
These risks are especially heightened during periods when labor markets are tight, as is currently the case. For example, the job turnover rate in the U.S. has skyrocketed to multi-decade highs as the voluntary quit rate among workers has spiked. This data is also backed by anecdotal evidence of workers leaving companies based on the widely held credence that employers offer higher salaries to external job candidates than to internal ones.
Under The Microscope: Consumer Discretionary Stocks
Nowhere is the low-pay and lack-of-workers conundrum more evident than in consumer discretionary stocks. This sector, which includes autos, retailers, hotels, restaurants, and other leisure goods and services, remains one of the sectors most reliant on labor. Indeed, within the S&P 500 companies, the market capitalization of the consumer discretionary sector is about 11%, and yet the sector accounts for over one-quarter of all the jobs available at all S&P 500 listed companies.
Among the eleven S&P 500 sectors, companies in the consumer discretionary basket are having the most trouble finding workers, as indicated by the second chart above.
It is notable then that companies in the consumer discretionary sector on average offer the lowest median wages and the average CEO-median worker pay gap is highest among the eleven sectors.
The above analysis may make it seem that this sector is particularly cutthroat. However, consumer discretionary stocks also have perhaps the most significant cost constraints: at just 6.5%, sector profit margins are far narrower than any other sector (ex. Energy) and well below the S&P500 average of 10.8%: it is difficult to take on extra costs, such as pay raises, when the cushion is so thin.
In this sense, consumer discretionary companies that dare to commit to raising wages are setting themselves apart; solving labor constraints could very well be a distinguishing indicator of long-term company success. In other words, given the acute labor shortage that consumer discretionary companies are facing, investors may well begin rewarding companies that raise wages despite the risk of a short-term knock to profitability.
Indeed, recent evidence to support this hypothesis can be found at two restaurant chains, McDonald’s and Chipotle. In May of this year, both companies hiked hourly wages at their firms. Neither companies’ stock prices were punished for voluntarily increasing their unit labor costs: McDonald’s equity price performance was initially positive and then flattened out several weeks after the announcement, while the strong rally in Chipotle stock prices has not ceased since wage hikes were announced.
Healthcare inequality, defined as uneven access to healthcare and disparate patient outcomes due to socio-economic factors, is a global phenomenon affecting individuals and families in both rich and poor nations. The COVID-19 pandemic exacerbated this by placing unparalleled demands on healthcare systems across the world, exposing major weaknesses and further amplifying significant gaps in healthcare inequality. However, the pandemic also caused a massive acceleration in the use of telehealth (i.e., virtual care), bringing forward positive structural changes with important implications for healthcare inequality.
Among developed nations, healthcare inequality is not unique to the US, but it is most pronounced there, affecting tens of millions. The high cost of healthcare in the US makes many individuals and families less financially secure, leading to reduced healthcare access and worse patient outcomes. Healthcare inequality is especially acute among the uninsured and underinsured, but it also directly impacts the chronically ill and many of the elderly. Despite the demands on the healthcare sector, even at the peak of the pandemic, it demonstrated incredible resiliency, responding with accelerated innovation and quickly adapting to disruption. The pharma and biotech industries delivered to market in record time multiple lifesaving vaccines while the telehealth industry provided care to millions of individuals remotely. The exceptional circumstances caused by the pandemic were a clear accelerant for the adoption of telehealth. The industry, which saw demand explode, transitioned from a complementary, value-added service, to a primary, low-cost way for patients to receive care independent of their location. The pandemic was a catalyst, not a temporary increase, for telehealth demand. Digitalisation and artificial intelligence carry enormous potential for telehealth to further transform the delivery of healthcare services. From an ESG perspective, this holds significant promise. In addition to obvious environmental benefits from reduced commuting, telehealth, driven by innovation and further adoption of digital solutions, is a catalyst to democratize healthcare and considerably reduce healthcare inequality.
The Affordable Care Act (ACA) introduced in 2010 intended in large part to reduce the number of Americans without health insurance. While the level of uninsured dropped by about 20 million since 2010, the total number of uninsured, non-elderly Americans in 2019 stood at nearly 29 million. Coupled with the number of underinsured individuals, usually due to rising premiums and deductibles, the total number of Americans impacted remains significant. According to KFF (a non-profit focusing on major healthcare issues) 28% of uninsured adults and 9% of insured adults reported delaying or foregoing medical care due to costs. Moreover, even in cases where individuals may be well-insured, access can still be an issue. For example, about a quarter of the US population does not have a regular primary care doctor and 83 million people live in areas where access to primary care is limited. This results in nearly double average wait times (29 days vs. 56 days) to see a primary care doctor in rural or smaller cities, further exacerbating healthcare inequality and leading to worse patient outcomes. In 2020, approximately 57 million people in the US lived in rural areas.
Telehealth eliminates the need for travel and streamlines cost-effective delivery of care for patients in rural settings. It’s also particularly beneficial for patients without a family physician who would have otherwise gone directly to an emergency room, and usually only when a condition worsened and required costlier intervention. A recent study found that 67% of patients would have gone to a hospital or urgent care if a telehealth option was not available. Moreover, Teladoc Health (TDOC US), a leading provider of virtual care services reported that 40% of its members who sought treatment for mental health said they would not have done so without a virtual option. Telehealth provides affordable and accessible care to patients which in turn makes them more inclined to seek care earlier and regularly. This results in expedited diagnoses and treatments, thus avoiding costlier options associated with emergency visits.

The US spends more on healthcare, both in absolute and per capita terms, than any other nation. In 2019 total expenditures on healthcare amounted to over USD3.8 trillion (~17% of GDP) or about 11k per capita.
The leading driver of these costs, accounting for 80-90%, is chronic disease like diabetes, heart disease, and high blood pressure. An additional USD1.1 trillion annually is estimated in lost productivity. According to the Centers for Disease Control (CDC), about six in ten Americans suffer from at least one chronic disease. Unfortunately, lower income groups with limited access to care suffer disproportionately and experience greater economic fallout from chronic disease. Moreover, such illnesses can also limit employment opportunities, leading to lower wages and further widening inequality gaps.
Chronic disease in the US, already highly prevalent, is expected to worsen in the coming years among all age cohorts. Regular access to primary and specialty care is crucial for proper management. Without such care, chronic disease can lead to serious complications and acute episodes requiring costly emergency interventions. Medication nonadherence is also a serious concern for patients with chronic diseases, affecting as many as 40% to 50% of patients, and is more common among low-income, uninsured patients. Nonadherence was higher for patients who did not receive information about their medications or did not regularly visit a primary health provider.
Telehealth can play a critical role in the management of chronic disease through a number of ways including increased access to care, remote monitoring, reduced costs for payors and patients, better predictability of events, and increased medication adherence. Patients with chronic diseases receiving regular medical care and support in medication and lifestyle management are more likely to remain engaged about their overall health, leading to improved drug adherence and outcomes. Over time, telehealth can reduce hospital readmissions and limit additional costs of care for both healthcare providers and patients.
The pandemic also pushed forward the consumerization of healthcare. The digital transformation is enabling greater access and control over one’s healthcare. According to Experian, a healthcare analytics firm, 78% of consumers want to be able to schedule their own appointments, at any time from their home or mobile device. Meanwhile, wearables like DexCom’s (DXCM US) diabetes glucose meter or iRhythm Technologies (IRTC US) ambulatory cardiac monitoring device, are increasing patient engagement and capitalizing on the gamification of healthcare, which increases medication adherence and wellbeing regiments. In other words, patients are seeking a more democratized, personalized healthcare experience and telehealth is at the center of this transformation.
The telehealth industry is supported by a perfect storm of secular catalysts. While demand has leveled off as the pandemic recedes, the structural shift in the industry is permanent and is in the early innings. According to Fortune Business Insights, the global telehealth market is expected to increase ninefold, growing from USD 61.4 billion in 2019 to USD 559 billion by 2027.
As a result, demand is likely to trend higher over the medium and long-term supporting industry leaders like Teladoc Health (TDOC US) and driving the IPO market for new listings, making a short position risky. The recent correction in telehealth provides an excellent entry point for investors to add new holdings.
Regulation is also evolving to support a wider adoption of telehealth. Since 2017 the Centers for Medicare & Medicaid Services (CMS) has steadily expanded the services that can be delivered via telehealth. During the pandemic CMS expanded coverage and loosened regulatory requirements allowing providers to be reimbursed at the same rate for virtual consults as in-person visits. These measures were meant to be a temporary emergency response to the pandemic, however, efforts to make changes permanent have bi-partisan support in Congress. This includes the Protecting Rural Telehealth Access Act, a recent bipartisan bill introduced by senators aimed at safeguarding rural telehealth access. The bill aims at ensuring underserved communities are able to continue accessing virtual care beyond the end of the pandemic.
While we are all sinners, some of us sin (or have sinned) much more than your average citizen, which typically empowers sectors such as pornography, weapons, alcohol, gambling, tobacco, etc. In this context, many ESG-minded investors who invest with their values typically look to avoid sin sectors. The problem with sins is that 1) the list grows by the day and 2) emerging sectors such as private prisons and internet gaming are also rapidly becoming part of an ESG-minded investor “no-no” list.
Today’s note looks back at some of our sins and at our “sin basket” themes. We evaluate the current opportunities to short some of them – in life but also in portfolios.
A first consideration is that over the past year, the pandemic has created a variety of societal pressures that have led to an increase in undesirous behavior. For instance, there has been a significant uptick in crime involving shootings as well as substance abuse rates. It seems that markets have also caught up with these trends: most traditional sin stocks having outperformed the S&P 500 since the beginning of the year.
On guns, a slew of shootings have occurred (up 30% over 2020 so far this year) and gun sales have also flared up at almost the same pace as shootings. To this end, profits of pure-play listed gunmakers have soared. As a result, we expect gun sales to continue to increase in the near-term. This should support stocks such as VSTO US (Vista Outdoors), SWBI US (Smith and Wesson) and RGR US (Sturm Ruger & Co), making it difficult to implement a short position at this point.

The fact that gun violence is treated as a U.S. public health issue – an epidemic in fact – and that the current administration is committed to rein it in has also encouraged Americans to exert their second amendment right. We think this trend will continue for some time as legislative action in Congress remains blockaded by Republican legislators. For these reasons, our naturally inclined short position on gun makers would hardly produce a result at this point. Nonetheless, we will monitor developments closely and wait for a more appropriate entry point. A trigger to our short position could occur when and if Republicans take back control of the Senate following the 2022 Mid-Term elections.
A second, perhaps more contextually appropriate short idea, could be to look at the private prisons theme in the United States. Here again, the current administration takes a radically different approach than the previous one in the way the Federal Administration and U.S. States should handle those who have truly sinned. The Biden administration is looking to terminate private prison contracts over the next few months. That said, a recent deferral court ruling over California’s private prison ban currently is supporting stock prices of private prison companies such as CXW US (CoreCivic) and GEO US (GEO Group). We do not think this is sustainable given the overarching political context and the need to reform the criminal justice system in the United States.
While the sector remains cheap and some of these companies still present strong fundamentals from a ‘value’ perspective (long-term PPP contracts, low P/E, etc.), we feel that the recent surge in equity prices in this sector are unwarranted given the political sensitivity of the private prison issue.
The equity market remains strongly short of CoreCivic and GEO Group, and this trend is unlikely trend to change anytime soon. A key risk would be that either of these two companies could be taken private at a higher multiple by a private equity group that is not too fussy about the social issues associated with the private prison theme.
As ESG investors, sportswear companies are generally not attractive as they often thrive on environment-damaging fast fashion. However, in terms of inspiration, they do come up with the catchiest slogans that we use to illustrate our topic this week.
Impossible is nothing (Adidas). We saw an unimaginably successful vaccine response. Prior to coronavirus COVID-19, no mRNA-based drug or vaccine had been licensed for use in humans and many pharmaceuticals were abandoning the technology. Now, the two mRNA vaccines are the most sought after. Excitement is palpable for curing some forms of cancer. Hopefully, this will be a spark for healthcare as a whole.
Forever faster (Puma). Improving productivity in the sector is required to keep the overall cost reasonable compared to other sectors. During the pandemic, experimentation was a necessity and it spurred ingenuity. Telehealth was live tested and holds large productivity improvement potential. Covid testing techniques will be applied to other existing health issues. Large-scale vaccine was deployed quickly and illustrated what can be accomplished. Device companies were involved in all of those aspects and will be a large part of the solution for productivity improvements with longer and healthier lives. For example, next-generation sequencing technology enabling streamlined research workflow for complete viral genome sequencing for SARS-CoV-2 were critical during this past year.
Reach beyond (Mizuho). Better health for longer at a reasonable cost; this is the goal.
I am what I am (Reebok). As people age, health issues occur naturally. All OECD countries witnessed an increase in the percentage of their population over 65 years old. Japan had the biggest increase with 11% more seniors than in 2000 for a total of 28% of its population. This trend will continue for the foreseeable future. Demographics change slowly. You cannot create a new 20-year-old. Health care needs will grow accordingly.
Health care costs are already a substantial and rising portion of most economies. If countries want to control spending, while still offering adequate health services to its population, then the equation that needs to be optimized is the occurrence of illnesses multiplied by the average cost of treating such illnesses. Rich nations tend to have higher rates of spending, with average spending around 10% of GDP. The United States is an outlier; at roughly 17% of GDP, health care spending is higher here due primarily to higher prices.
The fastest growing risk factors of death globally are all correlated to excess weight (high blood pressure, high blood sugar and obesity). This is not a rich world problem, many countries in South America and the Middle East are at the top of this unenviable list of countries.
In 1990, only 9 countries had more than 15% of death directly linked to obesity, but this figure increased to 51 countries by 2017. Contrary to general opinion, the United States is yet part of the group. Its obesity-linked death percentage jumped from 11% to 14% from 2000 to 2017. Globally, 13% of adults are obese with a body mass index over 30.
The reasons behind the rise in obesity and its health problems are complex and are beyond the scope of this report. Suffice to say, both the socioeconomic factors and individual behaviors involved in obesity are long-term and difficult to change.
Habits can change but it usually takes time. For this reason, companies active in health care have a positive long-term tailwind because an older and heavier population means more clients.
Sound mind, sound body (Asics). Prevention is the best tool to reduce the occurrence of illness. We have written about improving nutrition to improve health (see our notes “Veganomics: greening your plate and your portfolio”, May 9, 2019 and “Health is the New Wealth”, November 12, 2020) where we identified companies we expect to be winners and losers from the sustainable long-term investing trend of healthier living.
This is what it feels like (Under Armour). Apart from prevention, the next best things one can hope for are early detection to reduce the damage once an illness occurs, better effectiveness of the different remedies, and continued surveillance of the situation. Health care medical devices companies have a very strong fundamental edge in addressing the multiple issues for delivery of services.
Power Style (Fila). Detection, effectiveness and continued surveillance all benefit from greater utilization of medical devices and technological improvement. Telemedicine, behavioral science to improve health, artificial intelligence to improve diagnostics, genomics, and 3-D printing are amongst new approaches progressively deployed. They are no longer dreams and opportunities for future medical advances seem infinite.
Companies that provide medical devices have participated in the evolution of healthcare with clear innovations and strong financial performance. The high relative cost for health care of the United States has resulted in domination of the global health care devices market by US companies. The devices bring large productivity gains but have also benefitted from a generous pricing system. We never hear about a medical device in US industrial policy but the results are similar to China’ technology industrial policy where the sheer size of their market and some barriers to entry have created champions that use their home base to compete globally. The company names are not as well known as in other sectors but they have a large revenue base and provide a lot of well-paying jobs, according to ZipRecruiter.com, the average annual pay in the medical device industry is slightly above $78,000. Growth in revenues has been strong and looks to remain strong for the foreseeable future.
In the United States, Medicare is important for medical device companies. In their February 2021 paper “Getting the Right Price? The Impact of Competitive Bidding Program”, the authors found that the introduction of a competitive bidding program for durable medical equipment reduced the cost of the equipment by close to 50%. Similar processes will likely be expanded to cut costs. Although this could slow the tailwind of the industry for a period, it will not jeopardize its long-term outlook.
Time to play (Salomon). The SMS Health Care Devices Index has outpaced the health care sector as well as the stock market in general over the last five years. With an ageing population that will need more care and the need for productivity improvement in the sector, we expect health care devices company to continue to outpace the overall market.
«Never tell me the odds». In a March 2009 case study by Simon David Handelsmon called “Realities and Perceptions of Human Rights in the Mining Industry – A Case Study”, Rio Tinto was under analysis. The main conclusion was that since 2000, although there has been a vast improvement in the general sensitivity of the mining industry to human rights issues, the reality on the ground has not kept pace with the aspirational rhetoric of the companies. When the study came out, the mere thought that, merely 10 years later, a Rio Tinto chief executive officer would resign under pressure from shareholders over an inadequate response to the destruction of ancient Aboriginal heritage sites in Australia, would not have crossed somebody’s mind. Social issues can no longer be ignored.
Activist hedge funds typically invest in a company to initiate change, move the stock price higher, sell at a profit and get on to the next target. In a February 5, 2020 research article by Mark R. Desjardine and Rodolphe Durand called “Disentangling the effects of hedge fund activism on firm financial and social performance“, they analyzed data from 2000 to 2016 on activist hedge funds. They also conducted interviews with activist managers as well as leaders of companies that were targets of activists. They confirmed through their interviews that the motivation of activist hedge funds is to increase the value of their investments quickly by cutting costs, scaling back investments, restructuring assets, redistributing cash, and replacing board members. The approach is typically to accuse management of subpar corporate governance and demand changes. Their investment horizon being very short, their demands heavily discount future returns.
«This deal’s getting worse all the time». The table above compares the results of companies that were targets of activist hedge funds to those that were not. For the first two years following the appearance of an activist, the market value and profitability is better for targets than non-targets while cash flows and ESG performance deteriorates. Over a 5-year period, market value, profitability, cash flows and ESG measures are all significantly worse for targets. By that time, the activist hedge fund is long gone since their investment horizon rarely breaches 3 years.
«We would be honored if you joined us». In November 2020, the activist hedge fund Bluebell Capital sent a letter to Michel Landel, the lead independent director at Danone recommending that the role of CEO and Chairman of the Board be separated. They also asked to initiate a search for a new CEO because of his poor operational track record and questionable capital allocation choices. In December, Gilles Schnepp was appointed to the board as lead director.
The above graph shows the stock performance of Danone compared to its peers. Danone was a clear target for activists.
Moreover, its margins, cash flows and valuation were below its competitors.
«I am altering the deal. Pray I don’t alter it any further». In February, Bluebell had four requests: The first was to separate the functions of chairman and chief executive officer. The second was to appoint an independent chair. The third request was that the board of directors to strengthen, by integrating people with experience in mass consumption and the fourth, request was that Mr. Faber must be let go for a new general manager.
«Apology accepted». the Danone CEO was fired in March. Following the firing, Gilles Schnepp wrote in a shareholder letter that Danone will pursue some of the organisational changes set in motion by former boss Emmanuel Faber and said «We want to make clear this is an organisational framework only, leaving the incoming CEO all the latitude to design and execute his or her strategy”.
Danone is one of only ten companies in the world with a AAA rating from CDP, a leading environmental reporting framework. Mark Carney, the current UN special envoy for climate and former governor of the Bank of England and the Bank of Canada, mentions Danone in his new book as a model for the way it changed its corporate signature to “One planet, One health” and its governance structure to require stakeholders’ consideration.
The Danone story is still unfolding and our opinion on it is not completely formed. Were the long-term benefits to stakeholders maximized by the actions of the company or was it wasteful publicity? The activist shareholders got what they wanted. Since Bluebell wrang, the stock price has underperformed the French index, has done worst than Nestle but better than Unilever. It will be a very interesting case study for years to come. The activist tactics are clearly an attack on sustainability and long-termism.
The table above shows public companies that obtained a CDP AAA rating. As we can see, those companies believe sustainability is a competitive advantage. They also have high margins and strong cash flows that allow them to implement sustainability programs dear to ESG-minded investors and ESG rating agencies. To obtain that rating, you need to be extremely good on operations and spend quite a lot on glossy documents detailing those programs. If their stock performance falters, those companies may become targets for activist investors – just like Danone.
«Do or do not, there is no try». Natura is a company based in Brazil that is eco-friendly, sustainable and uses ordinary people as models to promote products. It changed its corporate structure to a B-Corp. Unusually, it does not have a very good CDP rating but its commitments to climate change, to protect the Amazon, to human rights, and to a circular economy make it very interesting. Philip Morris is AAA from CDP because its environmental practices and reporting are very good but considering its products kill people, it is tough to stomach. As a long term ESG investor, a BFF like Natura that aims for long-term improvements in life looks like a better investment partner than AAA-rated Philip Morris that destroys your health.
«Impressive, most impressive». The stock performance of Natura has been volatile but good compared to its CDP-AAA competitors L’Oréal and KAO. It will not be a target for activist hedge funds for now. If KAO continues to have poor performance, it could become a target.
«The son of Skywalker must not become a Jedi». The more demanding nature of younger participants in the economy is leading or coinciding with the evolution of institutional investors towards a greater emphasis on long term prospects. «Luminous beings are we. Not this crude matter». This presents a new hope for markets to play their ultimate role as optimal allocators of capital for the greater good of society. The road will be treacherous.
Perhaps the most surprising element of the U.S. administration’s call for a global minimum corporate tax is that it took so long to happen. Despite its bad reputation with the general public, tax avoidance has long been tolerated – if not even encouraged – by some OECD countries (e.g., Ireland). Others, such as France and the U.K. – who benefit from the proximity of complacent tax jurisdictions (Monaco and the Channel Islands, respectively) still support their high-earning companies (and individuals) in the fiercely competitive global economic game through such tax avoidance schemes.
It also seems that the IMF and other organizations are now all out about tax collection to finance monster COVID-related deficits – and they are now championing global cooperation on the issue. The good news is that similar to the fiscal and monetary response given to the COVID crisis, we see a high chance that governments will cooperate more seriously on the issue of tax evasion and tax avoidance to fund ever-growing government deficits.
In a note last year (see “ESG investors vs. the taxman”, January 9, 2020), we foresaw such an increase in America’s corporate tax rates following Trump’s fiscally unsustainable cuts of December 2017. The increase in corporate taxes is also on the radar as corporate America expects a solid earnings’ year from the COVID boost to several industries (Construction, Materials, Tech, etc.).
While many welcomed the previous White House’s reduction of the U.S.’ corporate tax rate to 21% – in-line with other developed countries – it seems that the new world in which we are living is asking for much stronger action, i.e. a substantial increase in corporate “tax effort”. In our note of last week (see “Working-class hero”, April 8, 2021), we underlined the decreasing tax effort of American corporations since 1950 as a share of GDP. It seems that governments are giving in to the “populist” impression that Big Business is not paying its fair share – and they are right.
In our note of January 2019, we had also suggested ESG-minded investors to engage with their investee companies on the issue – albeit a very delicate one for the asset management industry. Indeed, financials are often pointed as serial tax avoiders and important users of tax heavens to preserve profit margins. We also underlined that sectors most exposed to a change-of-tack in U.S. corporate tax policy were chemicals, hospitality, casinos, and tech sectors.
That said, investors – which are typically much more avid of tax cuts than they are about tax hikes – benefitted largely from Trump’s tax policies. In fact, the S&P 500 increased by about 7% in late 2017 following the enactment of Trump’s corporate tax plan.
Interestingly, the P/E ratio of the S&P 500 decreased following the tax cut announcement in a context of strong growth and a tight labor market.
While Biden’s tax plan will first target a 15% minimum tax rate on profits for companies in “high tax avoidance” industries with a minimum of USD 100 million of revenue, some sectors and industries will suffer more than others. In our view, sectors with high earnings’ yield and low effective tax rates could suffer some level of reputational risk as the Biden administration looks to re-tax corporate America.
One other way to look at where the IRS will find its “fiscal nuggets” is to look at corporate America’s “fiscal space” – i.e. its tax “effort” as a percentage of EBIT. Here, and perhaps surprisingly, one sees that cash paid in taxes as a percent of EBIT can represent a substantial portion of EBIT in industries such as apparel, hospitality, and systems software.
Conversely, the IRS could look for some corporate fiscal space in industries such as semiconductors, steel and passthrough structures such as REITs which display a much higher potential of being re-taxed.
Finally, Biden’s re-tax plan also sheds light on the current level of corporate welfare – which will likely come under greater scrutiny in the coming months. Here, the rather interventionist Biden administration will likely give back some of the money it will take through taxes to corporations that are in harmony with the agenda of the government.
According to the GoodJobsFirst NGO, subsidies to America’s 20 biggest “corporate welfare queens” amounted to more than USD 80 billion last year. This is something that certainly will be looked at by policymakers as they re-tax corporations in the months to come and unwind the unprecedented level of public support provided to corporates this past year.
Last week’s disastrous IPO of Deliveroo, another UK-based online delivery food company that offers poor working conditions to its “associates” is a sign that bad worker treatment may have met its Waterloo. Moreover, the attempt for unionization by Amazon’s workers in Bessemer, Alabama, is another indication that the tide may be turning in favor of workers.
From an ESG standpoint, we should be putting greater emphasis on worker treatment when evaluating the prospects of a company. Not only is this appropriate from a long-term sustainability standpoint, but it will likely coincide with a change in attitude from governments with regard to taxation, regulations and incentives.
Using CSRHub data, we looked at employee treatment scores for very large employers in the United States to see how it evolved over time. Employers like Home Depot, Kroger and Walmart are ranking among the better companies and have improving scores for the way they treat their employees. At the other end, gig economy companies like Uber, Lyft and Herbalife have very poor scores with no signs of improvement as we can see from the table below which shows data as of the end of 2020.
Employee treatment scores are yet to be released for DoorDash and Deliveroo as they have become public during the last year but we expect results similar to other gig economy companies. DoorDash has been called the worst of the gig companies by commentators for the payout Dashers receive.
The business model of Uber, Lyft, DoorDash and Deliveroo, where barriers of entry are low, seem to be predicated on poor conditions for employees in exchange for work flexibility. Herbalife has a different business model that focuses on recruitment more than on product sales. Close to 90% of Herbalife distributors make no money and the distributors at the top of the food chain benefit the most as they get a percentage of what their recruits purchase. Its checkered legal past and the 2016 movie Betting on Zero have permanently labelled the company as being controversial from a working condition standpoint.
Over the last two years, the poor performers from a worker treatment point of view have slightly trailed the good performers with much greater volatility. While no clear conclusion can be reached from this graph as the companies that comprise the SMS Good Working Conditions Index are larger and more stable than those in the SMS Bad Working Conditions Index, we think that going forward, a wedge could appear between both indices as markets start rewarding good performers over laggards. It is also interesting to see how both sets of companies reacted during the Covid crisis, with the “good” companies being a lot more resilient to the drawdown than the “bad” companies.
It’s been a hard day’s night for workers over the last 40 years as their share of total income in the United States has gone down consistently. The usual culprits of globalization and technological improvements are well-recognized but industry consolidation and intellectual property rules are also significant and they have been found to reduce competition which has favoured capital over labor.
At the same time, the share of US corporate profits after tax has gone up to compensate. Moreover, the share of corporate income taxes has gone in the opposite direction. Owners of capital have been handsomely rewarded with greater profits and less taxes to the relative detriment of workers. The rise of political activism for more fairness, nationalism and populism attests to the need for better distribution of wealth and a relative shift to wage-earners.
“She works hard for the money, so you better treat her right” is echoed by President Biden’s words last week when he said: “I’m a union guy, I support unions. Unions built the middle class, it’s about time they get a piece of the action.”

As we can see from the table above, nearly half of the U.S. total working population makes less than $30,000 per year. The middle class has been gutted. The United States has the worst GINI index, a measure of income disparity between citizens, amongst developed economies. This is unsustainable.
Right after its election, the new administration has pushed hard to support people by passing a huge stimulus bill along party lines. Unsurprisingly, the cash handouts provisions included in the bill are proving very popular with the electorate. The bill also made an aggressive proposal for infrastructure spending that aims to create jobs while increasing taxes for corporations and the wealthy. It is not clear how the proposal will turn out just yet but what we see it is that there is a clear attempt to better redistribute wealth.
The trend to prioritize jobs and wages over profits and fiscal rectitude will continue – especially if we consider that the White House now has on staff Janet Yellen and Cecilia Rouse, respectively Treasury Secretary and Chair of the Council of Economic Advisers, both well-known labor economists who’ve made labor issues a hallmark of their academic careers. In our view, after Covid, the job market may not go back to working 9 to 5 but we see a good chance that the administration will favor companies that are good job creators and will make life difficult for companies that are taking advantage of employees.
If, as we expect, labor starts to be favored by governments and regulators, there will be winners and losers and the relative performance will start to diverge and companies that treat their employees poorly will be on the losing end. ESG investors would be well-advised to consider worker treatment as a key performance metrics.